| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.19 | 0.004 |